CJC-1295 no DAC 2mg (Mod GRF 1-29)
$35.00
PRODUCT SHORT DESCRIPTION
CJC-1295 No DAC 2mg (Modified GRF 1-29) is a premium, high-purity synthetic peptide analogue engineered for advanced somatotropic signaling, neuroendocrine regulation, and pharmacokinetic stability research. This 2mg configuration provides a highly stable biochemical tool for investigating GHRH receptor affinity, adenylate cyclase activation, and pulsatile growth hormone mechanics.
CJC-1295 No DAC (Modified GRF 1-29) is a high-purity synthetic peptide analogue available at The Peptide Store, manufactured to ≥98% purity and rigorously verified by HPLC and mass spectrometry. Engineered as an advanced molecular tool for somatotropic signaling and neuroendocrine research, this compound is supplied exclusively for qualified laboratory and scientific investigation. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
CJC-1295 No DAC, also referred to as Modified GRF 1-29 or Tetrasubstituted GHRH(1-29), is a synthetic analogue of endogenous growth hormone-releasing hormone. Unlike its DAC-conjugated counterpart, this variant preserves the natural pulsatile characteristics of GHRH signaling, making it a preferred biochemical tool for researchers investigating physiological growth hormone secretion patterns. The Peptide Store offers this compound in a 2mg configuration, supplying investigators with a precise and reliable reagent for advanced endocrinological studies.
Peptide Structure & Amino Acid Sequence
CJC-1295 No DAC is a 29-amino acid peptide derived from the biologically active N-terminal core of endogenous GHRH. Four strategic amino acid substitutions have been incorporated into the sequence to enhance enzymatic resistance and receptor binding affinity without introducing a Drug Affinity Complex. These substitutions confer measurable improvements in biochemical stability while retaining the native receptor interaction profile critical for pulsatile growth hormone axis research. The molecular formula and sequence are consistent with internationally recognized analytical standards for Modified GRF 1-29.
Chemical & Physical Characteristics
- Common Name: CJC-1295 No DAC / Modified GRF 1-29
- Classification: Synthetic GHRH Analogue (Tetrasubstituted)
- Chain Length: 29 Amino Acids
- Molecular Weight: Approximately 3,367 Da
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in aqueous buffers under standard laboratory conditions
- Storage Temperature: −20°C (long-term); 2–8°C (short-term)
Purity & Analytical Verification (HPLC & MS)
Every batch of CJC-1295 No DAC supplied by The Peptide Store undergoes stringent analytical verification. Purity is confirmed at ≥98% via reverse-phase high-performance liquid chromatography (RP-HPLC), and molecular identity is validated through mass spectrometry (MS). These dual-verification protocols ensure that each 2mg vial meets the exacting standards required for reproducible, publication-grade research outcomes. Certificates of Analysis (CoA) are available upon request and reflect lot-specific analytical data.
Quality Control & Lyophilization Integrity
To preserve structural integrity and maximize shelf stability, CJC-1295 No DAC is processed via pharmaceutical-grade lyophilization. This freeze-drying methodology removes residual moisture under controlled vacuum conditions, producing a stable, free-flowing powder that resists degradation during transport and storage. Each vial is sealed under inert atmosphere to prevent oxidative damage. The Peptide Store’s quality control pipeline includes pre- and post-lyophilization testing to confirm that no structural alterations occur during the drying process.
Safety, Handling & Laboratory Precautions
CJC-1295 No DAC is intended exclusively for use by trained research professionals in appropriately equipped laboratory environments. Standard laboratory safety protocols should be observed at all times, including the use of personal protective equipment (PPE) such as gloves, eye protection, and lab coats. This compound should be handled in accordance with institutional biosafety guidelines. Researchers should consult applicable safety data sheets and institutional review protocols before initiating any experimental procedures involving this reagent.
Reconstitution, Packaging & Storage
CJC-1295 No DAC is supplied as a lyophilized powder in individually sealed, clearly labeled vials. For laboratory reconstitution, researchers should use sterile, research-grade aqueous solvents appropriate for their specific experimental protocol, following institutional SOPs. Once reconstituted, the solution should be stored at 2–8°C and used within a timeframe consistent with established peptide stability guidelines. Lyophilized stock should be maintained at −20°C and protected from repeated freeze-thaw cycles to preserve analytical integrity.
Intended Research Use & Market Positioning
CJC-1295 No DAC is positioned as a premier research-grade reagent for scientists investigating GHRH receptor pharmacology, pituitary somatotroph dynamics, adenylate cyclase activation pathways, and pulsatile growth hormone secretion mechanics. Its tetrasubstituted architecture makes it particularly valuable in comparative studies evaluating native versus analogue GHRH signaling. The Peptide Store supplies this compound to academic institutions, pharmaceutical research organizations, and independent laboratories seeking verified, high-purity peptides for sale at competitive pricing.
Ordering, Availability & Fulfillment
Researchers can buy CJC-1295 No DAC (Modified GRF 1-29) online directly through The Peptide Store. Orders are processed promptly, with secure packaging designed to maintain cold-chain integrity throughout transit. Bulk ordering options and institutional procurement inquiries are welcomed. Our fulfillment team ensures that all orders are dispatched efficiently, with tracking information provided upon shipment. Order now to secure your research supply at the best price available from a trusted, compliance-focused supplier.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 No DAC (Modified GRF 1-29) is sold exclusively as a laboratory reagent for in vitro and preclinical research purposes. The Peptide Store makes no claims regarding therapeutic efficacy, safety for biological administration, or suitability for any application outside of controlled scientific research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the acquisition, handling, and use of research peptides. This product is not intended to diagnose, treat, cure, or prevent any condition or disease.
Related products
CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC, Ipamorelin, and GHRP-2 formulation delivers an advanced, triple-action research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and distinct growth hormone secretagogue receptor signaling mechanics.
CJC-1295 no DAC 5mg (Mod GRF 1-29)
PRODUCT SHORT DESCRIPTION
CJC-1295 No DAC 5mg (Modified GRF 1-29) is a premium, high-purity synthetic peptide analogue engineered for advanced somatotropic signaling, neuroendocrine regulation, and pharmacokinetic stability research. This 5000mcg configuration provides a highly stable biochemical tool for investigating GHRH receptor affinity, adenylate cyclase activation, and pulsatile growth hormone mechanics.
GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-2 (5mg x 5) and CJC-1295 no DAC (5mg x 5)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing five 5mg vials of GHRP-2 alongside five 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-6 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-6 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-6 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-6 10mg
PRODUCT SHORT DESCRIPTION
GHRP-6 10mg is a premium, high-purity synthetic hexapeptide engineered for advanced somatotropic and metabolic axis evaluation. This 10mg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, intracellular signaling mechanisms, and pulsatile growth hormone (GH) transcription.
IGF-1 LR3 1mg
PRODUCT SHORT DESCRIPTION
IGF-1 LR3 1mg is a premium, high-potency synthetic 83-amino-acid analog of human Insulin-like Growth Factor-1. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, this 1000mcg configuration is engineered strictly for investigating sustained somatotropic signaling and uninhibited receptor binding kinetics.
Ipamorelin (2mg x 10), CJC-1295 no DAC (2mg x 10)
PRODUCT SHORT DESCRIPTION
The Ipamorelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 2mg vials of Ipamorelin alongside ten 2mg vials of CJC-1295 No DAC. This configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.

Reviews
There are no reviews yet.